ArcelorMittal SA vs Novavax Inc — how do they compare? ArcelorMittal SA trades at $73.73 (market cap $55.96B), while Novavax Inc trades at $7.96 (market cap $1.30B). The key difference: ArcelorMittal SA is far larger — about 43× Novavax Inc's market cap, and ArcelorMittal SA pays a 0.81% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| MT | NVAX | |
|---|---|---|
Market Cap | $55.96B | $1.30B |
Sector | Basic Materials | Health |
52-Week High | $75.35 | $11.19 |
52-Week Low | $32.44 | $6.22 |
Enterprise Value | $65.53B | $879.40M |
Dividend Yield | 0.81% | — |
Signals from Pluang's Aura AI — not financial advice
ArcelorMittal (MT) trades at $73.29, up 0.1% with bullish technical signals from moving averages despite recent earnings miss. The company shows improving fundamentals with Q2 2026 revenue growth and strong cash flow generation of $4.8B from operations. Recent corporate developments include dividend payments and strategic partnerships with Microsoft, while analyst consensus remains positive with 50% buy ratings.
Outlook remains cautiously optimistic with European business recovery potential, though risks include cyclical steel demand volatility and elevated debt levels. The stock offers value with reasonable P/S (0.89) and P/B (1.01) ratios, but investors should monitor execution on second-half shipment guidance and margin pressures from input costs.
Novavax (NVAX) trades at $7.95, up 2.71% with a bullish technical signal despite negative profitability metrics. The company shows mixed fundamentals with strong revenue growth to $1.12B in 2025 but negative net income margins. Recent Q2 2026 earnings beat expectations, and the company raised its 2026 revenue outlook while cutting expenses. Analyst sentiment remains positive with 74% buy ratings.
Investment outlook balances strong partnerships and pipeline potential against persistent cash burn and negative equity. The Sanofi collaboration and Matrix-M adjuvant platform offer growth catalysts, but operational losses and high debt levels present significant risks. Stock appears undervalued on some metrics but requires careful monitoring of cash flow sustainability.
Trailing returns across standard periods
ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →